Skip to content

AXIM BIOTECHNOLOGIES, INC.

AXIM

CIK 0001514946

← back to feed
Revenue (TTM)
$89.97K
+345.3% YoY Q2 Aug 2024
Net Income (TTM)
−$5.96M
−29.1% YoY Q2 Aug 2024
EPS Diluted (TTM)
−$0.03
0.0% YoY Q2 Aug 2024
Gross Margin
39.0%
Q2 Aug 2024
Operating Margin
-2,509.0%
Q2 Aug 2024
Net Margin
-6,621.2%
Q2 Aug 2024
Free Cash Flow (TTM)
−$1.66M
Q2 Aug 2024
Cash
$53.54K
Q2 Aug 2024
Total Debt
$5.97M
Q2 Aug 2024
Shares Outstanding
301.96M sh
Q2 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings